Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms

Cardiology and endocrinology often treat the heart and metabolism as separate domains. This review argues they are two ends of the same broken circuit — insulin resistance and endothelial dysfunction each driving the other.

The authors trace the shared molecular wiring. The same insulin-signaling pathways that govern glucose uptake also tell the endothelium to produce nitric oxide, the molecule that keeps vessels relaxed and healthy. When insulin signaling falters, both functions degrade together — blood sugar climbs while blood vessels stiffen and inflame — and each problem worsens the other in a feedback loop that underlies metabolic syndrome.

The practical takeaway follows from the coupling: improving one side tends to help the other, so interventions that restore insulin sensitivity (exercise, weight loss) also benefit the vasculature, and vice versa. The resistance is structural — specialties and treatment silos that manage diabetes and heart disease as if they were unrelated.

We rate the evidence solid for a mechanistic review: a deep, 179-reference, multidisciplinary synthesis from conflict-free, publicly funded authors. As a narrative review it can’t prove causation, but it builds a strong framework. Its clinical significance is moderate-to-high — it reframes metabolic and cardiovascular disease as one problem — though it synthesizes existing knowledge rather than testing a new treatment.